FIND

  Search for:    

 

News > Events > Stop TB Working Group  

Stop TB Working Group on New Diagnostics Convened
at the 36th Union World Conference on Lung Health, Paris, 18-22 Oct 2005
 
The annual meeting of the Stop TB Working Group on New Diagnostics October 19, 2005, brought together leading international delegates to review and discuss technology developments in TB. The well-attended working group meeting included an update on the Global Plan to Stop TB II, presentations on methods to advance point of care TB diagnostics, updates on technology applications and new approaches for diagnosing TB at the district level.

Four new subgroups for the Stop TB Working Group on New Diagnostics have been created:

  • Discovery Research
  • Diagnostic Trials
  • Market Entry
  • Advocacy

Membership is now open for these new subgroups. Interested parties can contact: info@finddiagnostics.com or
Dr. Jane Cunningham: cunninghamj@who.int

 

View Presentations from the Stop TB Working Group on New Diagnostics:

bullet Update on the Global Plan to Stop TB II, Dr. Jane Cunningham
bullet Filling Knowledge Gaps for the development of Point of Care TB Diagnostics:
  Serologic tests for TB: is there hope? Dr. Marila Gennaro [download pdf 1.2 Mb]
Comparative evaluation of marketed TB serologic tests, Dr. Jane Cunningham
[download pdf 1.1 Mb]
   
Brief updates: Dr. Jenny Harry, Proteome Systems
Dr. Tetsu Hase, Eiken
[download pdf 484 Kb]
bullet Diagnosing TB at the District Level, Dr. Haileyesus Getahun [download pdf 128Kb]
bullet LTBI Diagnostics, Dr. Luca Richeldi

More Information on the Stop TB Working Group on New Diagnostics can be found by visiting:
Stop TB Partnership website


Comments from the Stop TB Working Group

“We will be judged not if we make a TB test, but whether that test will make a difference,”
Chair Giorgio Roscigno, CEO FIND

“The ultimate goal of TB eradication in 2050 is innovation, innovation, innovation.”
Dr. Dermot Maher, Stop TB Dept., WHO Geneva

“There is most definitely hope for TB serology,” Dr. Marila Gennaro, PHRI, Newark

“(TB) diagnostics in development could span all areas and have impact on many other diseases,”
Andy Ramsay, TDR, WHO Geneva